Skip to content
ONIX logo blue
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Contact
ONIX logo blue
Contact
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
etch weekly update image

eCTD Industry Update (8 Feb 2022)

February 8, 2022
/
onix

EMA

  • Referrals document: Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products (updated)
  • Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes (updated)
  • Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure (updated)
  • Regulatory and procedural guideline: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes (updated)
  • Regulatory and procedural guideline: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure (updated)

CMDh

  • Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP - Clean version / Tracked version (update)
  • Practical guidance on the implementation of the Protocol on Ireland/Northern Ireland for medicinal products for human use approved via MRP/DCP - Clean version / Tracked version (update)
PrevThe Template Toolbar
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Twitter Linkedin

© Copyright 2023

ONIX Life Sciences Ltd, 59-60 Thames Street, Windsor, Berkshire, SL4 1TX.

ONIX Life Sciences Inc, 500 Delaware Ave, Ste 1 #1960, Wilmington, DE 19899, USA

ONIX Life Sciences Ltd, Salarpuria Sanctity, Kasavanahalli, Sarjapur Road, Bangalore 560035 India

+44 (0) 1753 257 904 | info@onixls.com | www.onixls.com

Privacy Policy